Work

Inhibition of Ras for cancer treatment: the search continues

Year: 2021

Type: article

Abstract: The RAS oncogenes (HRAS, NRAS and KRAS) comprise the most frequently mutated class of oncogenes in human cancers (33%), stimulating intensive effort in developing anti-Ras inhibitors for cancer treatment.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/6rwh-2111

Authors: Xu, Dapeng, Baines, Antonio T., Der, Channing J.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Protein Kinase Regulation and GTPase Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Awards: G9000071908, G9000174629, G9000329203

OpenAlex ID: W4298839619

FWCI:

Cites:

Cited by:

Related to: 10